// April 18, 2024
USP’s commitment to ESG considerations for a healthier, more sustainable world
At the U.S.
At the U.S.
The development of generic versions of innovator medicines is a global public health need.
To help strengthen the pharmaceutical supply chain and guard against potential shortages that can
We live in an age where the use of computers and software systems are directly integrated into th